Cargando…
The effect of long acting somatostatin analogue SMS 201.995 therapy on tumour kinetic measurements and serum tumour marker concentrations in primary rectal cancer.
Twelve patients with rectal carcinoma were treated for 2 weeks with the somatostatin analogue SMS 201.995. Effects of this therapy were assessed using serum marker concentration, Ki67 and gastrin-immunoreactivity of the primary tumour. In four out of 12 patients, a significant decrease in Ki67 immun...
Autores principales: | Iftikhar, S. Y., Watson, S. A., Morris, D. L. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1991
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1972528/ https://www.ncbi.nlm.nih.gov/pubmed/2069853 |
Ejemplares similares
-
The Effect of Long Acting Somatostatin Analogue SMS 201-995 in Acromegaly
por: Choi, Chul Joon, et al.
Publicado: (1987) -
Evaluation of the synthetic somatostatin analogue SMS 201-995 in patients with hypoglycaemia associated with hepatocellular carcinoma.
por: Joffe, B. I., et al.
Publicado: (1988) -
Inhibitory Effect of a Somatostatin Analogue (SMS 201–995) on the Growth of Androgen‐dependent Mouse Mammary Tumor (Shionogi Carcinoma 115)
por: Noguchi, Shinzaburo, et al.
Publicado: (1993) -
GH Secretory Dynamics and Responsiveness to SMS 201-995 Treatment in Acromegaly
por: Kim, Sung Woon, et al.
Publicado: (1988) -
A Comparison of Sms 201-995 and Oesophageal Tamponade in the Control of Acute Variceal Haemorrhage
por: Mckee, Ruth F., et al.
Publicado: (1992)